1. Home
  2. KB vs ILMN Comparison

KB vs ILMN Comparison

Compare KB & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KB Financial Group Inc

KB

KB Financial Group Inc

HOLD

Current Price

$85.19

Market Cap

31.3B

Sector

Finance

ML Signal

HOLD

Logo Illumina Inc.

ILMN

Illumina Inc.

HOLD

Current Price

$137.67

Market Cap

18.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KB
ILMN
Founded
2008
1998
Country
South Korea
United States
Employees
N/A
N/A
Industry
Commercial Banks
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.3B
18.9B
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
KB
ILMN
Price
$85.19
$137.67
Analyst Decision
Hold
Analyst Count
0
16
Target Price
N/A
$116.19
AVG Volume (30 Days)
123.6K
1.8M
Earning Date
02-04-2026
02-05-2026
Dividend Yield
2.37%
N/A
EPS Growth
31.42
N/A
EPS
10.70
4.46
Revenue
$10,599,662,483.00
$4,288,000,000.00
Revenue This Year
$17.52
N/A
Revenue Next Year
$2.13
$2.08
P/E Ratio
$7.76
$30.22
Revenue Growth
5.94
N/A
52 Week Low
$46.38
$68.70
52 Week High
$92.39
$153.06

Technical Indicators

Market Signals
Indicator
KB
ILMN
Relative Strength Index (RSI) 49.64 67.61
Support Level $83.85 $129.29
Resistance Level $86.70 $137.09
Average True Range (ATR) 1.20 3.94
MACD -0.25 -0.37
Stochastic Oscillator 27.37 91.74

Price Performance

Historical Comparison
KB
ILMN

About KB KB Financial Group Inc

KB Financial Group Inc. is a financial holding company in Korea. The company operations include Kookmin Bank, one of the commercial banks in Korea. The company's subsidiaries collectively engage in a broad range of businesses, including commercial banking, credit cards, asset management, non-life and life insurance, capital markets activities, and international banking and finance. The company's segments include the Banking business, Securities business, Non-life Insurance business, Credit card business, and Life Insurance business. The Group generates the majority of its revenue from the Banking business.

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Share on Social Networks: